Dynavax Technologies reported 47.66 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Adma Biologics 21.68 1.37 Jun/2025
Amgen 12.51 28.7 Jun/2025
AstraZeneca 20.04 12.31 Jun/2025
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Dynavax Technologies 47.66 38.52 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
Glaxosmithkline 18.39 3.81 Jun/2025
Merck 8.58 4.74 Jun/2025
Neurocrine Biosciences 42.61 5.9 Jun/2025
Novartis 15.89 3.03 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sarepta Therapeutics 27.27 0 Jun/2025
TG Therapeutics 88.77 52.63 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025